Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124547172 | 12454717 | 2 | F | 20160701 | 20160610 | 20160713 | EXP | ES-009507513-1606ESP004448 | MERCK | 55.00 | YR | F | Y | 0.00000 | 20160713 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124547172 | 12454717 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | UNK | U | 20903 | CAPSULE | |||||||||
| 124547172 | 12454717 | 2 | SS | INTERFERON ALFA-2B | INTERFERON ALFA-2B | 1 | UNK | U | 0 | POWDER FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124547172 | 12454717 | 1 | Chronic hepatitis C |
| 124547172 | 12454717 | 2 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124547172 | 12454717 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124547172 | 12454717 | Cutaneous sarcoidosis | |
| 124547172 | 12454717 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |